Amanote Research
Register
Sign In
Psy158 - A Pragmatic Literature Review to Identify Economic Outcomes for Repurposed Drugs in Rare Diseases
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.2732
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
E. Drane
K. Hanman
E. Walker
R.S. Thompson
Publisher
Elsevier BV
Related search
PUK2 Issues in the Systematic Review of Drugs for Rare Diseases: A Case Study of Eculizumab for aHUS
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Literature Review to Identify Factors That Determine Policies for Influenza Vaccination
Health Policy
Health Policy
The Need for Transparency and Efficiency in Reimbursement Decisions Relating to Drugs for Rare Diseases
Medical Decision Making
Health Policy
Prm127 - Economic Modelling Considerations in Rare Diseases: A Targeted Review of Highly Specialised Technology Appraisals
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Repurposed Anti-Cancer Drugs: The Future for Anti-Infective Therapy?
Expert Review of Anti-Infective Therapy
Virology
Infectious Diseases
Microbiology
Is the Current Approach to Reviewing New Drugs Condemning the Victims of Rare Diseases to Death? A Call for a National Orphan Drug Review Policy
CMAJ
Medicine
Is It Possible to Accurately Identify Rare Diseases Using National Hospital Discharge Databases?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
New Drugs for Mental Diseases?: New Diseases for Old Drugs?
Journal of the Royal Society of Medicine
Medicine
Rare and Hereditary Causes of Stroke-A Literature Review
